Boston Scientific Plans IRS Settlement
Executive Summary
Boston Sci plans to pay $275m to settle transfer-pricing disputes with the US Internal Revenue Service. A financial analyst views the settlement as a win for the company because it’s well below what the IRS initially sought.
You may also be interested in...
Boston Scientific Settles $610M Tax Dispute
The giant device-maker has settled a long-running dispute over transfer pricing with the US Internal Revenue Service. Boston Scientific expects to pay almost $610m in back taxes and interest.
Tax Court Backs Medtronic In Transfer-Payment Dispute
The ruling means a larger portion of the company’s earnings can be taxed at the lower rate applied to foreign corporations.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.